[1] 陈炜,赵磊,牛素平,等.不同炎症因子对细菌性血流感染所致脓毒症患者的早期诊断价值[J].中华危重病急救医学,2014,26(3):165-170.
[2] 黄鹏,张丽娜,艾宇航.脓毒症的流行病学特点及其死亡危险因素分析[J].中国急救医学,2012,32(10):929-932.
[3] 李爱林,袁鼎山.脓毒症患者血清CRP、STREM-1和PCT水平变化及其临床意义研究[J].东南大学学报(医学版),2018,37(4):729-733.
[4] 张德厚,陈义坤,刘大东.脓毒症患者早期血小板功能变化及预后分析[J/OL].中华危重症医学杂志(电子版),2017,10(1):28-33.
[5] LEVY M M,FINK M P,MARSHALL J C,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31(4):1250-1256.
[6] 段立伟,张晟,林兆奋.以Logistic回归模型构建联合预测因子对脓毒症诊断及预后判断的临床运用[J].中华危重病急救杂志,2017,29(2):139-144.
[7] 张华,钟白云,王新华,等.血清t-PSA及f-PSA/t-PSA联合诊断前列腺癌的价值评价[J].中国现代医学杂志,2014,24(7):24-27.
[8] MA S,HUANG J.Combinning multiple markers for classification using ROC[J].Biometrics,2007,63(3):751-757.
[9] LASKO T A,BHAGWAT J G,ZOU K H,et al.The use of receiver operating characteristic curves in biomedical informatics[J].J Biomed Inform,2005,38(5):404-415.
[10] 邵婧,徐萍萍,郭景景,等.血培养联合内毒素、降钙素原等检测对重症感染患者败血症的诊断价值[J].现代医学,2018,46(9):1029-1032.
[11] LIMPER M,DE KRUIF M,DUITS A,et al.The diagnostic role of procalcitionin and other biomarkers in discriminating infectious from non-infectious fever[J].J Infect,2010,60(6):409-416.
[12] LAYIOS N,LAMBERMONT B.Procalcitonin for antibiotic treatment in intensive care unit patients[J].Curr Infect Dis Rep,2013,15(5):394-399.
[13] 付鹤鹤,张玉想.脓毒症患者血小板功能障碍的机制研究进展[J].中国急救医学,2017,37(10):873-877.
[14] LEVI M.Platelets in Critical Illness[J].Semin Thromb Hemost,2016,42(3):252-257.
[15] KRAL J B,SCHROTTMAIER W C,SALZMANN M,et al.Platelet Interaction with Innate Immune Cells[J].Transfus Med Hemother,2016,43(2):78-88.
[16] 杨丽丽,马增,李川,等.降钙素原联合血小板检测对脓毒症诊断及判断预后的临床意义[J].检验医学与临床,2016,13(19):2752-2754. |